Mary Disis

Credentials: · ·

History

Institute of Translational Health Sciences
National Center for Advancing Translational Sciences · UL1
Contact PI · $69.2M · University of Washington
2017–2027
Institute of Translational Health Sciences
National Center for Advancing Translational Sciences · UL1
Contact PI · $49.4M · University of Washington
2007–2017
Institute of Translational Health Sciences
National Center for Advancing Translational Sciences · KL2
Contact PI · $12.6M · University of Washington
2007–2017
Institute of Translational Health Sciences
National Center for Advancing Translational Sciences · TL1
Contact PI · $2.1M · University of Washington
2007–2017

STEMVAC in Patients With Early Stage Triple Negative Breast Cancer
Principal investigator · Active not recruiting · Phase 2
University of Washington
2022–2028
TAEK-VAC-HerBy Vaccine for Brachyury and HER2 Expressing Cancer
Principal investigator · Completed · Phase 1
Bavarian Nordic
2020–2024
Vaccine Therapy in Treating Patients With Stage IV HLA-A2 and HER2 Positive Breast or Ovarian Cancer Receiving Trastuzumab
Principal investigator · Completed · Phase 1, Phase 2
University of Washington
2016–2023
Vaccine Therapy in Treating Patients With HER2-Negative Stage III-IV Breast Cancer
Principal investigator · Active not recruiting · Phase 1
University of Washington
2015–2026